Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Receives $175.33 Consensus Price Target from Analysts
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six ratings firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy […]
30 Dec 07:08 · The Markets Daily